Cerebrospinal fluid APOE levels: an endophenotype for genetic studies for Alzheimer's disease

By Cruchaga Carlos   Kauwe John S.K.   Nowotny Petra   Bales Kelly   Pickering Eve H.   Mayo Kevin   Bertelsen Sarah   Hinrichs Anthony   Fagan Anne M.   Holtzman David M.   Morris John C.   Goate Alison M.  

Human Molecular Genetics, Vol. 21, Iss. 20, 2012-10 ,pp. : 4558-4571

Oxford University Press

Access to resources Recommend Favorite

Variants of CYP46A1 may interact with age and APOE to influence CSF Aβ42 levels in Alzheimer’s disease

By Johansson Annica   Katzov Hagit   Zetterberg Henrik   Feuk Lars   Johansson Boo   Bogdanovic Nenad   Andreasen Niels   Lenhard Boris   Brookes Anthony   Pedersen Nancy   Blennow Kaj   Prince Jonathan  

Human Genetics, Vol. 114, Iss. 6, 2004-05 ,pp. : 581-587

Springer Publishing Company

Access to resources Recommend Favorite

A new polymorphism in the APOE promoter associated with risk of developing Alzheimer's Disease

By Lambert J-C.  

Human Molecular Genetics, Vol. 7, Iss. 3, 1998-03 ,pp. : 533-540

Oxford University Press

Access to resources Recommend Favorite

Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene

By Han S.W.  

Human Molecular Genetics, Vol. 7, Iss. 12, 1998-11 ,pp. : 1887-1892

Oxford University Press

Access to resources Recommend Favorite

APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels

By Klos Kathy   Shimmin Lawrence   Ballantyne Christie   Boerwinkle Eric   Clark Andrew   Coresh Josef   Hanis Craig   Liu Kiang   Sayre Scott   Hixson James  

Human Molecular Genetics, Vol. 17, Iss. 13, 2008-07 ,pp. : 2039-2046

Oxford University Press

Access to resources Recommend Favorite